My expectations for the outcome of prostate laser surgery were rather low as I had a lot of alarming and negative feedback from professionals concerning the state of urinary symptoms and bladder. Dr Frymann was straightforward in the management of my case. I was more than delighted and very surprised indeed by the outcome, having been told I was likely to be catheterised for the rest of my life by NHS medical staff - and I am now enjoying a normal life without a catheter. I am very grateful to Dr Frymann, and sorry to report how dissappointed I was to discover that the NHS could not offer the same standard of care in my region, and certainly never within a reasonable time frame. My HoLEP surgery was worth every penny.
It was Mr Fryman's job to tell me in May 2019 that I had incurable prostate cancer. This was a shock for which I was quite unprepared and frankly he seemed to be too. Whilst I valued his honesty and candour, I would have appreciated a little more in the way of bedside manner. It didn't help that this was our first meeting because the biopsy had been done not by him but by the registrar. My case was not prioritised and I had been kept waiting over 5 weeks to get my diagnosis. I was fortunate to be able to transfer away from Sussex Hospitals to a different NHS trust where the care has been excellent and so far I seem to have been able to do rather better than Mr Fryman's prognosis indicated although I believe his assessment was quite correct at the time.
Faultless care holep was a great success so pleased l chose this option. Highly recommend
Rob completed his undergraduate training at the University of Sheffield. His basic surgical training was under taken at St Richard’s Hospital in Chichester, followed by 2 years of research in Bristol working towards his MD thesis (looking into the treatment of benign prostatic obstruction). Rob was a specialist registrar in the South Thames region, which included a further year at St Richard’s Hospital, a year at Worthing Hospital, and a 2 year oncology (cancer) and laparoscopy fellowship in Newcastle, New South Wales, Australia.
Rob has been a consultant urological surgeon since 2008, specialising in laser surgery. Rob has built up a vast experience with Holmium laser enucleation of the prostate (HoLEP) and laser stone surgery for kidney stones. Since 2009 he has performed over 650 HoLEPs (up to 2022) and is currently doing over 100 HoLEP procedures a year. He has built a reputation for operating on men with very large, challenging prostates where the HoLEP procedure is the preferred option, although HoLEP is a great operation for any size of prostate.
Rob continues to audit his results to ensure excellent outcomes for his patients. Approximately 70% of the men having a HoLEP are catheterised and unable to pass urine at the time of surgery; the catheter free rate after surgery is 95% to 98%. The average pre-op PSA was 10.1 (range 0.01 to 102) and the average post-op PSA was 2.49 (range 0.06 to 26); the vast majority of patients find that their PSA falls and often is within the normal age specific range after a HoLEP. The average enucleated weight was 77.7g (range 1g to 197g). Post-op symptoms scores are low indicating that the majority of patients are either delighted or happy with their symptoms after the procedure (average IPSS score of 4.9 out of 35 (range 1 to 15) with a quality of life score of 0.84 out of 6 (range 0 to 4)).
Rob achieves a high stone free rate after laser stone surgery and tries to avoid leaving a ureteric stent after surgery if at all possible.
Rob has been consultant urological surgeon at Western Sussex Hospital (now University Hospitals Sussex) since July 2016. Prior to this appointment he was a consultant urological surgeon at the James Paget Hospital in Great Yarmouth (2008 to 2016), undertaking HoLEP, laser stone surgery and laparoscopic nephrectomy.
Short link to review Mr Robert Frymann: http://iwgc.net/een4g